Equity Profile
Post-Earnings Recap
Golub Capital BDC, Inc.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.04 | $6.96 | +18.71% |
| Revenue | — | $72.0B | — |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Novo Nordisk A/S is a global leader in diabetes care and hormone replacement therapies, operating in the Health Care sector. With a market cap of $197 billion, the company plays a crucial role in addressing chronic health issues, particularly diabetes, which affects millions worldwide.
EPS
Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
Total revenue reflects the company's sales performance and market demand for its products, which is critical for assessing growth.
Wall Street expectations, options signals, track record, and call prep available with Pro.
Franklin Resources, Inc.
14,702,508 sh · $605.3M
0.43%
5.1%
Morgan Stanley
12,842,089 sh · $528.7M
0.38%
3.5%
Bank of America Corporation
11,868,129 sh · $488.6M
0.35%
-11.5%
Capital International Investors
11,211,106 sh · $461.6M
0.33%
-36.7%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.